VectivBio Holding AG Ordinary Shares
VECT
VECT was delisted on the 7th of July, 2023.
21 hedge funds and large institutions have $168M invested in VectivBio Holding AG Ordinary Shares in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 3 closing their positions.
12% more capital invested
Capital invested by funds: $150M → $168M (+$17.4M)
5% less funds holding
Funds holding: 22 → 21 (-1)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CA
CHI Advisors
New York
|
+$1.83M |
| 2 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$898K |
| 3 |
Citigroup
New York
|
+$91K |
| 4 |
Barclays
London,
United Kingdom
|
+$42.4K |
| 5 |
Morgan Stanley
New York
|
+$12.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.65M |
| 2 |
CC
Caxton Corporation
Princeton,
New Jersey
|
-$292K |
| 3 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$244K |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$57K |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$16.3K |
VECT Hedge Fund Activity: Q3 2022 in Review
21 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in VectivBio Holding AG Ordinary Shares (VECT) for Q3 2022, worth a combined $168M — up 12% from $150M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of VECT and 2 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 5 added.
The largest buyer was CHI Advisors, adding an estimated $1.83M. The largest seller was Cormorant Asset Management, cutting an estimated $1.65M.
- 21 institutional investors held VectivBio Holding AG Ordinary Shares (VECT) as of Q3 2022, down from 22 in Q2 2022.
- Funds reported $168M of VectivBio Holding AG Ordinary Shares stock for Q3 2022, up 12% quarter-over-quarter.
- 2 funds opened new VectivBio Holding AG Ordinary Shares positions in Q3 2022 and 3 closed out, a net change of -1 holder.
- The largest VectivBio Holding AG Ordinary Shares buyer in Q3 2022 was CHI Advisors, an estimated $1.83M added.
- The largest VectivBio Holding AG Ordinary Shares seller in Q3 2022 was Cormorant Asset Management, an estimated $1.65M sold.
Based on aggregated 13F filings for Q3 2022.